The Roots Analysis team is putting in its best effort to offer our clients / readers a reliable source of information, regarding how the pharmaceutical and biotech sectors are coping in the midst of the COVID-19 pandemic. Our intention is to generate realistic insights, based on a variety of factors, which are anticipated to influence both prevalent and future market dynamics. Reach out to us for any help.

Pre-Sterilized / Ready-to-Use Primary Packaging Market: Focus on Cartridges, Syringes and Vials (2nd Edition) - Distribution by Type of Packaging System (Vials, Syringes, Cartridges and Closures), Packaging Material (Glass and Plastic) and Key Geography (North America, Europe, Asia Pacific, Latin America, Middle East and North Africa and Rest of the World), Industry Trends and Global Forecast, 2021-2030

  • Lowest Price Guaranteed From USD 5,499

  • Published
    April 2021

  • Pages
    297

  • View Count
    7156

Example Insights

Pre-Sterilized-Ready-to-Use-Primary-Packaging-Context Pre-Sterilized-Ready-to-Use-Primary-Packaging-List-of-Pre-Sterilized Pre-Sterilized-Ready-to-Use-Primary-Packaging-Distribution-by-Primary-Packaging-System Pre-Sterilized-Ready-to-Use-Primary-Packaging-Market landscape
Pre-Sterilized-Ready-to-Use-Primary-Packaging-Company-Competitiveness-Analysis Pre-Sterilized-Ready-to-Use-Primary-Packaging-Partnerships-and-Collaborations Pre-Sterilized-Ready-to-Use-Primary-Packaging-Key-Players Pre-Sterilized-Ready-to-Use-Primary-Packaging-Global-Demand
Pre-Sterilized-Ready-to-Use-Primary-Packaging-Recent-Trends Pre-Sterilized-Ready-to-Use-Primary-Packaging-Case-Study Pre-Sterilized-Ready-to-Use-Primary-Packaging-Opportunity  

 

Overview

Primary packaging, such as vials, syringes, and cartridges, and their affiliated closures, play a vital role in ensuring the stability, and sterility, and thereby, the overall quality, efficacy and safety of a drug product. Moreover, the packaging bears the product label, which provides information related to the drug and, in certain cases, dosing instructions. Pharmaceutical packaging is typically carried out under controlled conditions; specifically, for therapeutics that are designed for parenteral administration, fill / finish is carried out in sterile and aseptic environments. It is also crucial for innovators (or packaging service providers) to choose the appropriate, high quality primary packaging for their respective products; this is because the packaging material is in direct contact with the drug / therapy. Building and maintaining the necessary expertise and infrastructure to support pharmacological fill / finish is a capital-intensive ordeal. Further, the growing complexity of modern pharmacological interventions, such as monoclonal antibodies, cell and gene therapies (which are typically produced in small batches) and the gradual (but imminent) shift to personalized therapies, has prompted drug developers to look for leaner manufacturing and packaging solutions. In this context, cost optimization is important and one of the available ways to save both time and capital is by bypassing manual processing and sterilization of primary packaging and switching to ready-to-use (RTU) formats. 

Pre-sterilized RTU container-closure systems have gradually become very popular and are widely used in the modern pharmaceutical industry. As indicated earlier, such components significantly simplify the overall fill / finish process, primarily by eliminating the need for several additional steps (such as washing, drying and sterilization), which were previously required to prepare primary containers for filling. In other words, using RTU components helps improve operational efficiencies. Drug product manufacturers and fill / finish service providers claim that these off-the-shelf packing and closure systems, help them to better serve their clients in a timely and regulation-compliant manner. In this context, it is worth highlighting that RTU packaging systems were in high demand during the COVID-19 pandemic, when novel vaccines and experimental therapies needed to be produced and packaged for distribution in large quantities. The surge in demand for appropriate packaging solutions in adequate quantities, is likely to persist, significantly adding to the opportunity for RTU package and affiliated closure developers / suppliers. In future, as drug developers continue to strive to achieve greater flexibilities in their operations, we believe that the RTU packaging components market is likely to witness steady growth over the next decade.

Scope of the Report

The “Pre-Sterilized / Ready-to-Use Primary Packaging: Focus on Cartridges, Syringes and Vials (2nd Edition) - Market Distribution by Type of Packaging System (Vials, Syringes, Cartridges and Closures), Packaging Material (Glass and Plastic) and Key Geography (North America, Europe, Asia Pacific, Latin America, Middle East and North Africa and Rest of the World) – Global Forecast 2021-2030” report features an extensive study of the current market landscape and future potential of ready-to-use primary packaging components, including cartridges, syringes and vials, and their respective closure systems (such as stoppers, needle shields and plungers) over the next decade. The study features an in-depth analysis of the key drivers and trends related to this domain. Amongst other elements, the report includes:

  • A detailed assessment of the current market landscape of ready-to-use primary packaging components, featuring information on the type of container (vials, syringes, cartridges and others), type of fabrication material used (glass and plastic), sterilization technique used (ethylene oxide sterilization, steam sterilization, gamma irradiation, electron beam sterilization and dry heat sterilization), volume of container (less than 50 ml, 50 ml to 100 ml and more than 100 ml), compatible drug class (biologics and small molecules) and type of closure (stoppers, plungers, tip caps / needle shields, caps and seals). In addition, the chapter includes details related to ready-to-use packaging system manufacturers, along with information on their respective year of establishment, company size, location of headquarters and key players (in terms of number of offerings).
  • A competitiveness analysis of ready-to-use primary packaging system manufacturers based on various relevant parameters, such as supplier power (based on the experience / expertise of the manufacturer) and key product specifications (type of container, type of fabrication material used, type of closure, sterilization technique used and compatible drug class).
  • Elaborate profiles of prominent players engaged in the development of ready-to-use primary packaging systems. Each profile features a brief overview of the company, details related to its financials (if available), product portfolio, recent developments and an informed future outlook.
  • An analysis of the partnerships that have been inked by stakeholders engaged in this domain, during the period 2015-2021, covering acquisitions, product / technology integration agreements, supply agreements, product / technology licensing agreements, product / technology development agreements, service alliances, distribution agreements and other relevant types of deals.
  • An insightful discussion on the impact of the recent COVID-19 pandemic on the businesses of primary pharmaceutical packaging manufacturers. In addition, we have provided information on the strategic initiatives undertaken by pharmaceutical players to mitigate the challenges affiliated with the current global crisis. 
  • An in-depth analysis to estimate the current and future demand for ready-to-use container-closure systems based on various relevant parameters, such as type of packaging system and type of fabrication material used, across different regions, for the period 2021-2030.
  • An elaborate discussion on the key trends (such as the advent of personalized / targeted therapies, shift towards more flexible packaging, rise of modular manufacturing facilities and advancement in robotic packaging solutions) that are likely to have an impact on the future adoption of ready-to-use packaging systems. It also features a Harvey ball analysis, highlighting the relative effect of each trend on the overall pharmaceutical packaging industry.
  • A case study on the use of robotic machinery in pharmaceutical manufacturing and fill / finish operations, highlighting the advantages of using automation / automated technologies in such processes. Further, it presents the profiles of industry players that provide such equipment for aseptic processing of pharmaceuticals. 

One of the key objectives of the report was to estimate the existing market size and identify potential growth opportunities for RTU primary packaging over the coming decade. Based on several parameters, such as target consumer segments, region specific adoption rates and expected prices of these products, we have provided an informed estimate on the likely evolution of the market over the period 2021-2030. The report provides sales forecasts for the overall RTU primary packaging market, wherein both the current and upcoming opportunity is segmented across [A] type of packaging system (vials, syringes, cartridges and closures), [B] type of fabrication material used (glass and plastic) and [C] key geographies (North America, Europe, Asia Pacific, Middle East and North Africa, Latin America and Rest of the world). In order to account for future uncertainties and to add robustness to our model, we have provided three market forecast scenarios, namely conservative, base and optimistic scenarios, representing different tracks of the industry’s growth.
The opinions and insights presented in this study were influenced by discussions conducted with multiple stakeholders in this domain. The report features detailed transcripts of interviews held with the following individuals:

  • Julien Marechal (Business Development and Technology Director, Aseptic Technologies)
  • Malcolm Gilmore (Facilitator, BioPhorum Operations Group)
  • Konstantin Kazarian (Former Project Manager of Business Development, PYRAMID Laboratories)
  • Daxesh Shah (Founder and Managing Director, Sagar Rubber)

Key Question Answered

  • Who are the prominent players engaged in the global pre-sterilized / ready-to-use primary packaging market?
  • What is the relative competitiveness of different ready-to-use primary packaging system manufacturers?
  • Which partnership models are most commonly adopted by stakeholders engaged in this industry?
  • How is the recent COVID-19 pandemic likely to impact the global ready-to-use primary packaging systems market?
  • What is the current, global demand for ready-to-use containers and closures?
  • What are the major market trends and driving factors that are likely to impact the growth of ready-to-use primary packaging systems market?
  • How is the current and future opportunity likely to be distributed across key market segments?

Contents

Chapter Outlines

Chapter 2 is an executive summary of the key insights presented in our report. It offers a high-level view on the current state of the ready-to-use primary packaging systems market and its likely evolution in the short-mid term and long term.

Chapter 3 provides an overview of conventional pharmaceutical packaging and the limitations associated with the currently used container-closure systems. The chapter lays emphasis on innovation in the pharmaceutical packaging industry and the consequent growth of flexible fill / finish solutions. It also presents information on pre-sterilized / ready-to-use primary packaging components. Further, it features an elaborate discussion on the various techniques used for sterilization of different primary packaging materials.

Chapter 4 provides a comprehensive review of the current market landscape of ready-to-use primary packaging components, featuring information on the (A) Containers: Type of container (vials, syringes, cartridges and others), type of fabrication material (glass and plastic), sterilization technique used (ethylene oxide sterilization, steam sterilization, gamma irradiation, electron beam sterilization and dry heat sterilization), volume of container (less than 50 ml, 50 ml to 100 ml and more than 100 ml) and compatible drug class (biologics and small molecules); (B) Closures: Type of closure (stoppers, plungers, tip caps / needle shields, caps and seals), type of fabrication material (rubber, plastic and metal), type of compatible container (vial, syringe and cartridge), sterilization technique used (gamma irradiation, steam sterilization, ethylene oxide sterilization, electron beam sterilization and beta irradiation) and compatible drug class (biologics and small molecules), and (C) Container-Closure System: Type of container (vials, syringes and cartridges), type of fabrication material for container (glass and plastic), type of closure (stopper, plunger, tip cap / needle shield and cap), type of fabrication material for closure (rubber and plastic), sterilization technique used (steam sterilization, ethylene oxide sterilization, gamma irradiation, dry heat sterilization and electron beam sterilization), volume of container (less than 25 ml, 25 ml to 50 ml and more than 50 ml) and compatible drug class (biologics and small molecules). In addition, the chapter includes details related to ready-to-use packaging system manufacturers, along with information on their respective year of establishment, company size, location of headquarters and key players (in terms of number of offerings.

Chapter 5 presents a detailed competitiveness analysis of ready-to-use primary packaging system manufacturers based on various relevant parameters, such as supplier power (based on the experience / expertise of the manufacturer) and key product specifications (type of container, type of fabrication material used, type of closure, sterilization technique used and compatible drug class). 

Chapter 6 features detailed profiles of the prominent companies that develop ready-to-use primary packaging systems. Each company profile features a brief overview of the company, details related to its financials (if available), product portfolio, recent developments and an informed future outlook. 

Chapter 7 features an analysis of the partnerships that have been inked by stakeholders engaged in this domain, in the period 2015 - 2020. It includes a brief description of various partnership models (acquisitions, product / technology integration agreements, supply agreements, product / technology licensing agreements, product / technology development agreements, service alliances, distribution agreements and other relevant types of deals). In addition, it includes a detailed analysis of partnerships based on year of partnership, type of partnership, location of partners and other relevant parameters.

Chapter 8 highlights the impact of the recent COVID-19 pandemic on the primary pharmaceutical packaging market. In addition, it features a brief discussion on the strategic initiatives undertaken by pharmaceutical players to mitigate the challenges associated with the current global crisis.

Chapter 9 provides an overview of the current and future demand for ready-to-use primary packaging components, including vials, syringes, cartridges and closures, in the contemporary market. In order to estimate the aforementioned demand, we considered the current supply of different primary packaging components and their respective closures and estimated their proportion that are likely to be supplied to the pharmaceutical industry. We also estimated the likely adoption of such products across geographical regions, over the period 2021-2030.

Chapter 10 discusses the emerging trends in the overall pharmaceutical manufacturing and fill-finish industry. Specifically, it presents the growing demand of personalized therapies, shift towards more flexible packaging, development of modular facilities, upgrading packaging components to enhance drug product safety, increase in partnership activity, and growing adoption of smart packaging solutions.

Chapter 11 presents a detailed case study on the role of robots in the pharmaceutical manufacturing and fill / finish process, highlighting its benefits and capabilities. It provides a list of the various types of pharmaceutical robots, along with details on their respective manufacturer and applications. Additionally, the chapter features profiles of players that offer robotic equipment for pharmaceutical manufacturing and fill / finish operations, along with information on the key specifications of their respective machinery.  

Chapter 12 presents a comprehensive market forecast analysis, highlighting the future potential of the market till 2030, based on multiple parameters, such as current demand for respective packaging components, likely adoption rates and the estimated price of components. It includes future sales projections of various closures of key packaging containers. We have segregated the current and upcoming opportunity based on [A] type of primary packaging system (vials, syringes, cartridges and closures), [B] type of fabrication material used (glass and plastic) and [C] key geographies (North America, Europe, Asia Pacific, Middle East and North Africa, Latin America and Rest of the world). It is worth mentioning that we adopted a bottom-up approach for this analysis, backing our claims with relevant datapoints and credible inputs from primary research.

Chapter 13 summarizes the overall report. In this chapter, we have provided a list of key takeaways from the report, and expressed our independent opinion related to the research and analysis described in the previous chapters.

Chapter 14 is a collection of interview transcripts of the discussions held with key stakeholders in this market. In this chapter, we have presented the details of interviews held with Julien Marechal (Business Development and Technology Director, Aseptic Technologies); Malcolm Gilmore (Facilitator, BioPhorum Operations Group), Konstantin Kazarian (Former Project Manager of Business Development, PYRAMID Laboratories) and Daxesh Shah (Founder and Managing Director, Sagar Rubber).

Chapter 15 is an appendix, which provides tabulated data and numbers for all the figures provided in the report.

Chapter 16 is an appendix, which contains the list of companies and organizations mentioned in the report.

Table Of Contents

1. PREFACE
1.1. Scope of the Report
1.2. Research Methodology
1.3. Key Questions Answered
1.4. Chapter Outlines

2. EXECUTIVE SUMMARY 

3. INTRODUCTION
3.1. Chapter Overview
3.2. Pharmaceutical Packaging
3.2.1. Necessity of Pharmaceutical Packaging
3.2.2. Types of Pharmaceutical Packaging
3.2.3. Limitations of Traditional Primary Packaging
3.2.4. Innovation in Pharmaceutical Packaging

3.3. Ready-to-Use Primary Packaging
3.3.1. Sterilization of Primary Packaging Material
3.3.1.1. Sterilization Techniques
3.3.2. Advantages of Ready-to-Use Primary Packaging
3.3.3. Cost Savings with Ready-To-Use Solutions
3.3.4. Demand for Ready-to-Use Primary Packaging
3.3.5 Concluding Remarks

4. MARKET LANDSCAPE
4.1. Chapter Overview
4.2. Pre-Sterilized / Ready-to-Use Primary Packaging: Overall Market Landscape
4.2.1. Analysis by Type of Primary Packaging System

4.3. Pre-Sterilized / Ready-to-Use Containers
4.3.1. Analysis by Type of Container
4.3.2. Analysis by Type of Fabrication Material Used
4.3.3. Analysis by Type of Container and Type of Fabrication Material Used
4.3.4. Analysis by Sterilization Technique Used
4.3.5. Analysis by Type of Container and Sterilization Technique Used
4.3.6. Analysis by Volume of Container
4.3.7. Analysis by Type of Container and Volume of Container
4.3.8. Analysis by Compatible Drug Class
4.3.9. Analysis by Type of Container and Compatible Drug Class

4.4. Pre-Sterilized / Ready-to-Use Closures
4.4.1. Analysis by Type of Closure
4.4.2. Analysis by Type of Fabrication Material Used
4.4.3. Analysis by Type of Closure and Type of Fabrication Material Used
4.4.4. Analysis by Type of Compatible Container
4.4.5. Analysis by Type of Closure and Type of Compatible Container
4.4.6. Analysis by Sterilization Technique Used
4.4.7. Analysis by Type of Closure and Sterilization Technique Used
4.4.8. Analysis by Compatible Drug Class
4.4.9. Analysis by Type of Closure and Compatible Drug Class

4.5. Pre-Sterilized / Ready-to-Use Container-Closure Systems
4.5.1. Analysis by Type of Container
4.5.2. Analysis by Type of Fabrication Material Used for Container
4.5.3. Analysis by Type of Container and Type of Fabrication Material Used for Container
4.5.4. Analysis by Type of Closure
4.5.5. Analysis by Type of Fabrication Material Used for Closure
4.5.6. Analysis by Type of Closure and Type of Fabrication Material Used for Closure
4.5.7. Analysis by Sterilization Technique Used
4.5.8. Analysis by Volume of Container
4.5.9. Analysis by Compatible Drug Class

4.6. Pre-Sterilized / Ready-to-Use Primary Packaging: List of Manufacturers
4.6.1. Analysis by Year of Establishment
4.6.2. Analysis by Company Size
4.6.3. Analysis by Location of Headquarters
4.6.6. Leading Manufacturers: Analysis by Number of Products

5. COMPANY COMPETITIVENESS ANALYSIS
5.1. Chapter Overview
5.2. Assumptions and Key Parameters
5.3. Methodology
5.3.1. Company Competitiveness: Small Companies
5.3.2. Company Competitiveness: Mid-Sized Companies
5.3.3. Company Competitiveness: Large Companies

6. COMPANY PROFILES
6.1. Chapter Overview
6.2. AptarGroup
6.2.1. Company Overview
6.2.2. Financial Information
6.2.3. AptarGroup: Product Portfolio
6.2.3.1. Ready-to-Use Closures
6.2.4. Recent Developments and Future Outlook

6.3. Datwyler Group
6.3.1. Company Overview
6.3.2. Financial Information
6.3.3. Datwyler Group: Product Portfolio
6.3.3.1. Ready-to-Use Closures
6.3.4. Recent Developments and Future Outlook

6.4. DWK Life Sciences
6.4.1. Company Overview
6.4.2. DWK Life Sciences: Product Portfolio
6.4.2.1. Ready-to-Use Container-Closure Systems
6.4.3. Recent Developments and Future Outlook

6.5. Gerresheimer
6.5.1. Company Overview
6.5.2. Financial Information
6.5.3. Gerresheimer: Product Portfolio
6.5.3.1. Ready-to-Use Containers
6.5.4. Recent Developments and Future Outlook

6.6. Ningbo Zhengli Pharmaceutical Packaging
6.6.1. Company Overview
6.6.2. Ningbo Zhengli Pharmaceutical Packaging: Product Portfolio
6.6.2.1. Ready-to-Use Containers
6.6.3. Recent Developments and Future Outlook

6.7. Nipro
6.7.1. Company Overview
6.7.2. Financial Information
6.7.3. Nipro: Product Portfolio
6.7.3.1. Ready-to-Use Containers
6.7.3.2. Ready-to-Use Closures
6.7.4. Recent Developments and Future Outlook

6.8. SCHOTT
6.8.1. Company Overview
6.8.2. Financial Information
6.8.3. SCHOTT: Product Portfolio
6.8.3.1. Ready-to-Use Containers
6.8.3.2. Ready-to-Use Closures
6.8.4. Recent Developments and Future Outlook

6.9. SGD Pharma
6.9.1. Company Overview
6.9.2. Financial Information
6.9.3. SGD Pharma: Product Portfolio
6.9.3.1. Ready-to-Use Containers
6.9.4. Recent Developments and Future Outlook

6.10. Stevanato Group
6.10.1. Company Overview
6.10.2. Stevanato Group: Product Portfolio
6.10.2.1. Ready-to-Use Containers
6.10.2.2. Ready-to-Use Closures
6.10.2.3. Ready-to-Use Container-Closure Systems
6.10.3. Recent Developments and Future Outlook

6.11. Terumo Medical
6.11.1. Company Overview
6.11.2. Terumo Medical: Product Portfolio
6.11.2.1. Ready-to-Use Containers
6.11.3. Recent Developments and Future Outlook

6.12. Transcoject
6.12.1. Company Overview
6.12.2. Transcoject: Product Portfolio
6.12.2.1. Ready-to-Use Containers
6.12.3. Recent Developments and Future Outlook

6.13. West Pharmaceutical Services
6.13.1. Company Overview
6.13.2. Financial Information
6.13.3. West Pharmaceutical Services: Product Portfolio
6.13.3.1. Ready-to-Use Containers
6.13.3.2. Ready-to-Use Closures
6.13.3.3. Ready-to-Use Container-Closure Systems
6.13.3. Recent Developments and Future Outlook

7. PARTNERSHIPS AND COLLABORATIONS
7.1. Chapter Overview
7.2. Partnership Models
7.3. Pre-Sterilized / Ready-to-Use Primary Packaging: List of Partnerships and Collaborations
7.3.1. Analysis by Year of Partnership
7.3.2. Analysis by Type of Partnership
7.3.3. Analysis by Year and Type of Partnership
7.3.4. Analysis by Type of Primary Packaging System
7.3.5. Analysis by Type of Fabrication Material Used
7.3.6. Analysis by Type of Partner
7.3.7. Most Active Players: Analysis by Number of Partnerships
7.3.8. Geographical Analysis
7.3.8.1. Region-wise Distribution
7.3.8.2. Country-wise Distribution

8. IMPACT OF THE COVID-19 PANDEMIC ON PRE-STERILIZED / READY-TO-USE PRIMARY PACKAGING MARKET
8.1. Chapter Overview
8.2. Impact of COVID-19 Pandemic on Primary Packaging Market
8.2.1. Impact on Future Market Opportunity of Pre-Sterilized/ Ready-to-Use Primary Packaging
8.3. Key Strategies to Mitigate Pandemic-related Challenges
8.4. Current Opinions and Recuperative Initiatives of Key Players
8.4.1. Becton Dickinson
8.4.2. Corning
8.4.3. Datwyler Group
8.4.4. Gerresheimer
8.4.5. SCHOTT
8.4.6. SiO2 Materials Science
8.4.7. Stevanato Group
8.4.8. West Pharmaceutical Services
8.4.9. Other Recent Developments

9. DEMAND ANALYSIS
9.1. Chapter Overview
9.2. Scope and Methodology
9.3. Global Demand for Pre-Sterilized / Ready-to-Use Primary Packaging System, 2021-2030

9.3.1. Analysis by Type of Pre-Sterilized / Ready-to-Use Primary Packaging System
9.3.1.1. Global Demand for Pre-Sterilized / Ready-to-Use Vials, 2021-2030
9.3.1.2. Global Demand for Pre-Sterilized / Ready-to-Use Syringes, 2021-2030
9.3.1.3. Global Demand for Pre-Sterilized / Ready-to-Use Cartridges, 2021-2030
9.3.1.4. Global Demand for Pre-Sterilized / Ready-to-Use Closures, 2021-2030

9.3.2. Analysis by Type of Fabrication Material Used
9.3.2.1. Global Demand for Pre-Sterilized / Ready-to-Use Glass Containers, 2021-2030
9.3.2.1.1. Global Demand for Pre-Sterilized / Ready-to-Use Glass Vials, 2021-2030
9.3.2.1.2. Global Demand for Pre-Sterilized / Ready-to-Use Glass Syringes, 2021-2030
9.3.2.1.3. Global Demand for Pre-Sterilized / Ready-to-Use Glass Cartridges, 2021-2030

9.3.2.2. Global Demand for Pre-Sterilized / Ready-to-Use Plastic Containers, 2021-2030
9.3.2.2.1. Global Demand for Pre-Sterilized / Ready-to-Use Plastic Vials, 2021-2030
9.3.2.2.2. Global Demand for Pre-Sterilized / Ready-to-Use Plastic Syringes, 2021-2030
9.3.2.2.3. Global Demand for Pre-Sterilized / Ready-to-Use Plastic Cartridges, 2021-2030

9.3.3. Analysis by Geography
9.3.3.1. Demand for Pre-Sterilized / Ready-to-Use Primary Packaging Systems in North America, 2021-2030
9.3.3.1.1. Demand for Pre-Sterilized / Ready-to-Use Vials in North America, 2021-2030
9.3.3.1.2. Demand for Pre-Sterilized / Ready-to-Use Syringes in North America, 2021-2030
9.3.3.1.3. Demand for Pre-Sterilized / Ready-to-Use Cartridges in North America, 2021-2030
9.3.3.1.4. Demand for Pre-Sterilized / Ready-to-Use Closures in North America, 2021-2030

9.3.3.2. Demand for Pre-Sterilized / Ready-to-Use Primary Packaging Systems in Europe, 2021-2030
9.3.3.2.1. Demand for Pre-Sterilized / Ready-to-Use Vials in Europe, 2021-2030
9.3.3.2.2. Demand for Pre-Sterilized / Ready-to-Use Syringes in Europe, 2021-2030
9.3.3.2.3. Demand for Pre-Sterilized / Ready-to-Use Cartridges in Europe, 2021-2030
9.3.3.2.4. Demand for Pre-Sterilized / Ready-to-Use Closures in Europe, 2021-2030

9.3.3.3. Demand for Pre-Sterilized / Ready-to-Use Primary Packaging Systems in Asia Pacific, 2021-2030
9.3.3.3.1. Demand for Pre-Sterilized / Ready-to-Use Vials in Asia Pacific, 2021-2030
9.3.3.3.2. Demand for Pre-Sterilized / Ready-to-Use Syringes in Asia Pacific, 2021-2030
9.3.3.3.3. Demand for Pre-Sterilized / Ready-to-Use Cartridges in Asia Pacific, 2021-2030
9.3.3.3.4. Demand for Pre-Sterilized / Ready-to-Use Closures in Asia Pacific, 2021-2030

9.3.3.4. Demand for Pre-Sterilized / Ready-to-Use Primary Packaging Systems in Middle East and North Africa, 2021-2030
9.3.3.4.1. Demand for Pre-Sterilized / Ready-to-Use Vials in Middle East and North Africa, 2021-2030
9.3.3.4.2. Demand for Pre-Sterilized / Ready-to-Use Syringes in Middle East and North Africa, 2021-2030
9.3.3.4.3. Demand for Pre-Sterilized / Ready-to-Use Cartridges in Middle East and North Africa, 2021-2030
9.3.3.4.4. Demand for Pre-Sterilized / Ready-to-Use Closures in Middle East and North Africa, 2021-2030

9.3.3.5. Demand for Pre-Sterilized / Ready-to-Use Primary Packaging Systems in Latin America, 2021-2030
9.3.3.5.1. Demand for Pre-Sterilized / Ready-to-Use Vials in Latin America, 2021-2030
9.3.3.5.2. Demand for Pre-Sterilized / Ready-to-Use Syringes in Latin America, 2021-2030
9.3.3.5.3. Demand for Pre-Sterilized / Ready-to-Use Cartridges in Latin America, 2021-2030
9.3.3.5.4. Demand for Pre-Sterilized / Ready-to-Use Closures in Latin America, 2021-2030

9.3.3.6. Demand for Pre-Sterilized / Ready-to-Use Primary Packaging Systems in Rest of the World, 2021-2030
9.3.3.6.1. Demand for Pre-Sterilized / Ready-to-Use Vials in Rest of the World, 2021-2030
9.3.3.6.2. Demand for Pre-Sterilized / Ready-to-Use Syringes in Rest of the World, 2021-2030
9.3.3.6.3. Demand for Pre-Sterilized / Ready-to-Use Cartridges in Rest of the World, 2021-2030
9.3.3.6.4. Demand for Pre-Sterilized / Ready-to-Use Closures in Rest of the World, 2021-2030

9.4. Concluding Remarks

10. UPCOMING TRENDS IN PHARMACEUTICAL PACKAGING
10.1. Chapter Overview
10.2. Shift to Self-Medication Options using Modern Drug Delivery Devices
10.3. Development of Improved Packaging Components and Efforts to Optimize Manufacturing Costs
10.4. Availability of Modular Facilities
10.5. Growing Demand and Preference for Personalized Therapies
10.6. Rise in Provisions for Automating Fill / Finish Operations
10.7. Surge in Partnership Activity
10.8. Increase in Initiatives Undertaken by Industry Stakeholders in Developing Regions
10.9. Concluding Remarks

11. CASE STUDY: ROBOTS IN PHARMACEUTICAL PACKAGING
11.1. Chapter Overview
11.2. Role of Robots in the Pharmaceutical Industry
11.2.1. Key Considerations for Selecting a Robotic System
11.2.2. Advantages of Robotic Systems
11.2.3. Disadvantages of Robotic Systems

11.3. Companies Providing Robots for Use in the Pharmaceutical Industry
11.4. Companies Providing Equipment Integrated with Robotic Systems for Pharmaceutical Packaging
11.4.1. Aseptic Technologies
11.4.2. AST
11.4.3. Bosch Packaging Technology
11.4.4. Dara Pharmaceutical Packaging
11.4.5. Fedegari Group
11.4.6. IMA
11.4.7. Steriline
11.4.8. Vanrx Pharmasystems

12. MARKET FORECAST AND OPPORTUNITY ANALYSIS
12.1. Chapter Overview
12.2. Forecast Methodology and Key Assumptions
12.3. Global Pre-Sterilized / Ready-to-Use Primary Packaging Market, 2021-2030
12.3.1. Pre-Sterilized / Ready-to-Use Primary Packaging Market, 2021-2030: Distribution by Type of Primary Packaging System
12.3.1.1. Pre-Sterilized / Ready-to-Use Vials Market, 2021-2030
12.3.1.2. Pre-Sterilized / Ready-to-Use Syringes Market, 2021-2030
12.3.1.3. Pre-Sterilized / Ready-to-Use Cartridges Market, 2021-2030
12.3.1.4. Pre-Sterilized / Ready-to-Use Closures Market, 2021-203

12.3.2. Pre-Sterilized / Ready-to-Use Primary Packaging Market, 2021-2030: Distribution by Type of Fabrication Material Used
12.3.2.1. Pre-Sterilized / Ready-to-Use Glass Containers Market, 2021-2030
12.3.2.1.1. Pre-Sterilized / Ready-to-Use Glass Vials Market, 2021-2030
12.3.2.1.2. Pre-Sterilized / Ready-to-Use Glass Syringes Market, 2021-2030
12.3.2.1.3. Pre-Sterilized / Ready-to-Use Glass Cartridges Market, 2021-2030

12.3.2.2. Pre-Sterilized / Ready-to-Use Plastic Containers Market, 2021-2030
12.3.2.2.1. Pre-Sterilized / Ready-to-Use Plastic Vials Market, 2021-2030
12.3.2.2.2. Pre-Sterilized / Ready-to-Use Plastic Syringes Market, 2021-2030
12.3.2.2.3. Pre-Sterilized / Ready-to-Use Plastic Cartridges Market, 2021-2030

12.3.3. Pre-Sterilized / Ready-to-Use Primary Packaging Market, 2021-2030: Distribution by Geography
12.3.3.1. Pre-Sterilized / Ready-to-Use Primary Packaging Market in North America, 2021-2030
12.3.3.1.1. Pre-Sterilized / Ready-to-Use Vials Market in North America, 2021-2030
12.3.3.1.2. Pre-Sterilized / Ready-to-Use Syringes Market in North America, 2021-2030
12.3.3.1.3. Pre-Sterilized / Ready-to-Use Cartridges Market in North America, 2021-2030
12.3.3.1.4. Pre-Sterilized / Ready-to-Use Closures Market in North America, 2021-2030

12.3.3.2. Pre-Sterilized / Ready-to-Use Primary Packaging Market in Europe, 2021-2030
12.3.3.2.1. Pre-Sterilized / Ready-to-Use Vials Market in Europe, 2021-2030
12.3.3.2.2. Pre-Sterilized / Ready-to-Use Syringes Market in Europe, 2021-2030
12.3.3.2.3. Pre-Sterilized / Ready-to-Use Cartridges Market in Europe, 2021-2030
12.3.3.2.4. Pre-Sterilized / Ready-to-Use Closures Market in Europe, 2021-2030

12.3.3.3. Pre-Sterilized / Ready-to-Use Primary Packaging Market in Asia-Pacific, 2021-2030
12.3.3.3.1. Pre-Sterilized / Ready-to-Use Vials Market in Asia-Pacific, 2021-2030
12.3.3.3.2. Pre-Sterilized / Ready-to-Use Syringes Market in Asia-Pacific, 2021-2030
12.3.3.3.3. Pre-Sterilized / Ready-to-Use Cartridges Market in Asia-Pacific, 2021-2030
12.3.3.3.4. Pre-Sterilized / Ready-to-Use Closures Market in Asia-Pacific, 2021-2030

12.3.3.4. Pre-Sterilized / Ready-to-Use Primary Packaging Market in Middle East and North Africa, 2021-2030
12.3.3.4.1. Pre-Sterilized / Ready-to-Use Vials Market in Middle East and North Africa, 2021-2030
12.3.3.4.2. Pre-Sterilized / Ready-to-Use Syringes Market in Middle East and North Africa, 2021-2030
12.3.3.4.3. Pre-Sterilized / Ready-to-Use Cartridges Market in Middle East and North Africa, 2021-2030
12.3.3.4.4. Pre-Sterilized / Ready-to-Use Closures Market in Middle East and North Africa, 2021-2030

12.3.3.5. Pre-Sterilized / Ready-to-Use Primary Packaging Market in Latin America, 2021-2030
12.3.3.5.1. Pre-Sterilized / Ready-to-Use Vials Market in Latin America, 2021-2030
12.3.3.5.2. Pre-Sterilized / Ready-to-Use Syringes Market in Latin America, 2021-2030
12.3.3.5.3. Pre-Sterilized / Ready-to-Use Cartridges Market in Latin America, 2021-2030
12.3.3.5.4. Pre-Sterilized / Ready-to-Use Closures Market in Latin America, 2021-2030

12.3.3.6. Pre-Sterilized / Ready-to-Use Primary Packaging Market in Rest of the World, 2021-2030
12.3.3.6.1. Pre-Sterilized / Ready-to-Use Vials Market in Rest of the World, 2021-2030
12.3.3.6.2. Pre-Sterilized / Ready-to-Use Syringes Market in Rest of the World, 2021-2030
12.3.3.6.3. Pre-Sterilized / Ready-to-Use Cartridges Market in Rest of the World, 2021-2030
12.3.3.6.4. Pre-Sterilized / Ready-to-Use Closures Market in Rest of the World, 2021-2030

13. CONCLUSION

14. EXECUTIVE INSIGHTS
14.1. Chapter Overview
14.2. Aseptic Technologies
14.2.1. Company Snapshot
14.2.2. Interview Transcript: Julien Maréchal, Business Development and Technology Director

14.3. BioPhorum Operations Group
14.3.1. Company Snapshot
14.3.2. Interview Transcript: Malcolm Gilmore, Facilitator

14.4. PYRAMID Laboratories
14.4.1. Company Snapshot
14.4.2. Interview Transcript: Konstantin Kazarian, Former Project Manager of Business Development

14.5. Sagar Rubber
14.5.1. Company Snapshot
14.5.2. Interview Transcript: Daxesh Shah, Founder and Managing Director

15. APPENDIX 1: TABULATED DATA

16. APPENDIX 2: LIST OF COMPANIES AND ORGANIZATIONS

List Of Figures

Figure 3.1 Traditional Aseptic Pharmaceutical Filling Process
Figure 3.2 Advantages of Pharmaceutical Packaging
Figure 3.3 Types of Pharmaceutical Packaging
Figure 3.4 Innovation in Pharmaceutical Packaging and Value Chain
Figure 3.5 Ready-to-Use Enabled Flexible, Aseptic Processing
Figure 3.6 Advantages of Ready-to-Use Platforms
Figure 3.7 Cost Comparison of Ready-to-Use and Conventional Container Systems
Figure 3.8 Drivers of Ready-to-Use Platform
Figure 4.1 Pre-Sterilized / Ready-to-Use Primary Packaging: Distribution by Type of Primary Packaging System
Figure 4.2 Pre-Sterilized / Ready-to-Use Containers: Distribution by Type of Container
Figure 4.3 Pre-Sterilized / Ready-to-Use Containers: Distribution by Type of Fabrication Material Used
Figure 4.4 Pre-Sterilized / Ready-to-Use Containers: Distribution by Type of Container and Type of Fabrication Material Used
Figure 4.5 Pre-Sterilized / Ready-to-Use Containers: Distribution by Sterilization Technique Used
Figure 4.6 Pre-Sterilized / Ready-to-Use Containers: Distribution by Type of Container and Sterilization Technique Used
Figure 4.7 Pre-Sterilized / Ready-to-Use Containers: Distribution by Volume of Container
Figure 4.8 Pre-Sterilized / Ready-to-Use Containers: Distribution by Type of Container and Volume of Container
Figure 4.9 Pre-Sterilized / Ready-to-Use Containers: Distribution by Compatible Drug Class
Figure 4.10 Pre-Sterilized / Ready-to-Use Containers: Distribution by Type of Container and Compatible Drug Class
Figure 4.11 Pre-Sterilized / Ready-to-Use Closures: Distribution by Type of Closure
Figure 4.12 Pre-Sterilized / Ready-to-Use Closures: Distribution by Type of Fabrication Material Used
Figure 4.13 Pre-Sterilized / Ready-to-Use Closures: Distribution by Type of Closure and Type of Fabrication Material Used
Figure 4.14 Pre-Sterilized / Ready-to-Use Closures: Distribution by Type of Compatible Container
Figure 4.15 Pre-Sterilized / Ready-to-Use Closures: Distribution by Type of Closure and Type of Compatible Container
Figure 4.16 Pre-Sterilized / Ready-to-Use Closures: Distribution by Sterilization Technique Used
Figure 4.17 Pre-Sterilized / Ready-to-Use Closures: Distribution by Type of Closure and Sterilization Technique Used
Figure 4.18 Pre-Sterilized / Ready-to-Use Closures: Distribution by Compatible Drug Class
Figure 4.19 Pre-Sterilized / Ready-to-Use Closures: Distribution by Type of Closure and Compatible Drug Class
Figure 4.20 Pre-Sterilized / Ready-to-Use Container-Closure Systems: Distribution by Type of Container
Figure 4.21 Pre-Sterilized / Ready-to-Use Container-Closure Systems: Distribution by Type of Fabrication Material Used for Container
Figure 4.22 Pre-Sterilized / Ready-to-Use Container-Closure Systems: Distribution by Type of Container and Type of Fabrication Material Used for Container
Figure 4.23 Pre-Sterilized / Ready-to-Use Container-Closure Systems: Distribution by Type of Closure
Figure 4.24 Pre-Sterilized / Ready-to-Use Container-Closure Systems: Distribution by Type of Fabrication Material Used for Closure
Figure 4.25 Pre-Sterilized / Ready-to-Use Container-Closure Systems: Distribution by Type of Closure and Type of Fabrication Material Used for Closure
Figure 4.26 Pre-Sterilized / Ready-to-Use Container-Closure Systems: Distribution by Sterilization Technique Used
Figure 4.27 Pre-Sterilized / Ready-to-Use Container-Closure Systems: Distribution by Volume of Container
Figure 4.28 Pre-Sterilized / Ready-to-Use Container-Closure Systems: Distribution by Compatible Drug Class
Figure 5.1 Company Competitiveness Analysis: Small Players
Figure 5.2 Company Competitiveness Analysis: Mid-Sized Players
Figure 5.3 Company Competitiveness Analysis: Large Players
Figure 6.1 AptarGroup: Annual Revenues, 2016-2020 (USD Billion)
Figure 6.2 Datwyler Group: Annual Revenues, 2016-2020 (CHF Billion)
Figure 6.3 Gerresheimer Group: Annual Revenues, 2016 - 9M 2020 (EUR Billion)
Figure 6.4 Nipro: Annual Revenues, 2016-2020 (JPY Billion)
Figure 6.5 SCHOTT: Annual Revenues, 2016-2020 (EUR Billion)
Figure 6.6 West Pharmaceutical Services: Annual Revenues, 2016-2020 (USD Billion)
Figure 7.1 Partnerships and Collaborations: Cumulative Year-wise Trend, 2015-2020
Figure 7.2 Partnerships and Collaborations: Distribution by Type of Partnership
Figure 7.3 Partnerships and Collaborations: Year-wise Trend by Type of Partnership
Figure 7.4 Partnerships and Collaborations: Distribution by Type of Primary Packaging System
Figure 7.5 Partnerships and Collaborations: Year-wise Trend by Type of Primary Packaging System
Figure 7.6 Partnerships and Collaborations: Distribution by Type of Fabrication Material Used
Figure 7.7 Partnerships and Collaborations: Year-wise Trend by Type of Fabrication Material Used
Figure 7.8 Partnerships and Collaborations: Distribution by Analysis by Type of Partner
Figure 7.9 Partnerships and Collaborations: Year-wise Trend by Analysis by Type of Partner
Figure 7.10 Most Active Players: Distribution by Number of Partnerships
Figure 7.11 Partnerships and Collaborations: Distribution by Region (Continent-wise)
Figure 7.12 Partnerships and Collaborations: Distribution by Region (Country-wise)
Figure 8.1. Pre-Sterilized / Ready to Use Primary Packaging Market, 2021-2030: COVID-19 Impact Scenario (USD Billion)
Figure 8.2. Strategic Initiatives Undertaken by Ready-to-Use Containers and Closures Manufacturers During COVID-19 pandemic
Figure 9.1. Global Demand for Pre-Sterilized / Ready-to-Use Primary Packaging Systems, 2021-2030 (Billion Units)
Figure 9.2. Global Demand for Pre-Sterilized / Ready-to-Use Vials, 2021-2030 (Billion Units)
Figure 9.3. Global Demand for Pre-Sterilized / Ready-to-Use Syringes, 2021-2030 (Billion Units)
Figure 9.4. Global Demand for Pre-Sterilized / Ready-to-Use Cartridges, 2021-2030 (Billion Units)
Figure 9.5. Global Demand for Pre-Sterilized / Ready-to-Use Closures, 2021-2030 (Billion Units)
Figure 9.6. Global Demand for Pre-Sterilized / Ready-to-Use Primary Packaging Systems: Distribution by Type of Fabrication Material Used, 2021 and 2030
Figure 9.7. Global Demand for Pre-Sterilized / Ready-to-Use Glass Containers, 2021-2030 (Billion Units)
Figure 9.8. Global Demand for Pre-Sterilized / Ready-to-Use Glass Vials, 2021-2030 (Billion Units)
Figure 9.9. Global Demand for Pre-Sterilized / Ready-to-Use Glass Syringes, 2021-2030 (Billion Units)
Figure 9.10. Global Demand for Pre-Sterilized / Ready-to-Use Glass Cartridges, 2021-2030 (Billion Units)
Figure 9.11. Global Demand for Pre-Sterilized / Ready-to-Use Plastic Containers, 2021-2030 (Billion Units)
Figure 9.12. Global Demand for Pre-Sterilized / Ready-to-Use Plastic Vials, 2021-2030 (Billion Units)
Figure 9.13. Global Demand for Pre-Sterilized / Ready-to-Use Plastic Syringes, 2021-2030 (Billion Units)
Figure 9.14. Global Demand for Pre-Sterilized / Ready-to-Use Plastic Cartridges, 2021-2030 (Billion Units)
Figure 9.15. Global Demand for Pre-Sterilized / Ready-to-Use Primary Packaging Systems: Distribution by Geography, 2021 and 2030
Figure 9.16. Demand for Pre-Sterilized / Ready-to-Use Vials in North America, 2021-2030 (Billion Units)
Figure 9.17. Demand for Pre-Sterilized / Ready-to-Use Syringes in North America, 2021-2030 (Billion Units)
Figure 9.18. Demand for Pre-Sterilized / Ready-to-Use Cartridges in North America, 2021-2030 (Billion Units)
Figure 9.19. Demand for Pre-Sterilized / Ready-to-Use Closures in North America, 2021-2030 (Billion Units)
Figure 9.20. Demand for Pre-Sterilized / Ready-to-Use Vials in Europe, 2021-2030 (Billion Units)
Figure 9.21. Demand for Pre-Sterilized / Ready-to-Use Syringes in Europe, 2021-2030 (Billion Units)
Figure 9.22. Demand for Pre-Sterilized / Ready-to-Use Cartridges in Europe, 2021-2030 (Billion Units)
Figure 9.23. Demand for Pre-Sterilized / Ready-to-Use Closures in Europe, 2021-2030 (Billion Units)
Figure 9.24. Demand for Pre-Sterilized / Ready-to-Use Vials in Asia Pacific, 2021-2030 (Billion Units)
Figure 9.25. Demand for Pre-Sterilized / Ready-to-Use Syringes in Asia Pacific, 2021-2030 (Billion Units)
Figure 9.26. Demand for Pre-Sterilized / Ready-to-Use Cartridges in Asia Pacific, 2021-2030 (Billion Units)
Figure 9.27. Demand for Pre-Sterilized / Ready-to-Use Closures in Asia Pacific, 2021-2030 (Billion Units)
Figure 9.28. Demand for Pre-Sterilized / Ready-to-Use Vials in Middle East and North Africa, 2021-2030 (Billion Units)
Figure 9.29. Demand for Pre-Sterilized / Ready-to-Use Syringes in Middle East and North Africa, 2021-2030 (Billion Units)
Figure 9.30. Demand for Pre-Sterilized / Ready-to-Use Cartridges in Middle East and North Africa, 2021-2030 (Billion Units)
Figure 9.31. Demand for Pre-Sterilized / Ready-to-Use Closures in Middle East and North Africa, 2021-2030 (Billion Units)
Figure 9.32. Demand for Pre-Sterilized / Ready-to-Use Vials in Latin America, 2021-2030 (Billion Units)
Figure 9.33. Demand for Pre-Sterilized / Ready-to-Use Syringes in Latin America, 2021-2030 (Billion Units)
Figure 9.34. Demand for Pre-Sterilized / Ready-to-Use Cartridges in Latin America, 2021-2030 (Billion Units)
Figure 9.35. Demand for Pre-Sterilized / Ready-to-Use Closures in Latin America, 2021-2030 (Billion Units)
Figure 9.36. Demand for Pre-Sterilized / Ready-to-Use Vials in Rest of the World, 2021-2030 (Billion Units)
Figure 9.37. Demand for Pre-Sterilized / Ready-to-Use Syringes in Rest of the World, 2021-2030 (Billion Units)
Figure 9.38. Demand for Pre-Sterilized / Ready-to-Use Cartridges in Rest of the World, 2021-2030 (Billion Units)
Figure 9.39. Demand for Pre-Sterilized / Ready-to-Use Closures in Rest of the World, 2021-2030 (Billion Units)
Figure 10.1 Upcoming Trends Related to Pharmaceutical Packaging
Figure 10.2 Future Growth Opportunities for Pre-Sterilized / Ready-to-Use Containers and Closures Market
Figure 11.1 Key Considerations for Selecting a Robotic System
Figure 11.2 Advantages Associated with Use of Robotic Systems in Pharmaceutical Manufacturing
Figure 12.1 Processing Costs: Distribution by Type of Packaging Component
Figure 12.2 Global Pre-Sterilized / Ready-to-Use Primary Packaging Market, 2021-2030 (USD Billion)
Figure 12.3 Pre-Sterilized / Ready-to-Use Vials Market, 2021-2030 (USD Billion)
Figure 12.4 Pre-Sterilized / Ready-to-Use Syringes Market, 2021-2030 (USD Billion)
Figure 12.5 Pre-Sterilized / Ready-to-Use Cartridges Market, 2021-2030 (USD Billion)
Figure 12.6 Pre-Sterilized / Ready-to-Use Closures Market, 2021-2030 (USD Billion)
Figure 12.7 Pre-Sterilized / Ready-to-Use Primary Packaging Market, 2021-2030: Distribution by Type of Fabrication Material Used (USD Billion)
Figure 12.8 Pre-Sterilized / Ready-to-Use Glass Containers Market, 2021-2030 (USD Billion)
Figure 12.9 Pre-Sterilized / Ready-to-Use Glass Vials Market, 2021-2030 (USD Billion)
Figure 12.10 Pre-Sterilized / Ready-to-Use Glass Syringes Market, 2021-2030 (USD Billion)
Figure 12.11 Pre-Sterilized / Ready-to-Use Glass Cartridges Market, 2021-2030 (USD Billion)
Figure 12.12 Pre-Sterilized / Ready-to-Use Plastic Containers Market, 2021-2030 (USD Billion)
Figure 12.13 Pre-Sterilized / Ready-to-Use Plastic Vials Market, 2021-2030 (USD Billion)
Figure 12.14 Pre-Sterilized / Ready-to-Use Plastic Syringes Market, 2021-2030 (USD Billion)
Figure 12.15 Pre-Sterilized / Ready-to-Use Plastic Cartridges Market, 2021-2030 (USD Billion)
Figure 12.16 Pre-Sterilized / Ready-to-Use Primary Packaging Market, 2021-2030: Distribution by Geography (USD Billion)
Figure 12.17 Pre-Sterilized / Ready-to-Use Primary Packaging Market in North America, 2021-2030 (USD Billion)
Figure 12.18 Pre-Sterilized / Ready-to-Use Vials Market in North America, 2021-2030 (USD Billion)
Figure 12.19 Pre-Sterilized / Ready-to-Use Syringes Market in North America, 2021-2030 (USD Billion)
Figure 12.20 Pre-Sterilized / Ready-to-Use Cartridges Market in North America, 2021-2030 (USD Billion)
Figure 12.21 Pre-Sterilized / Ready-to-Use Closures Market in North America, 2021-2030 (USD Billion)
Figure 12.22 Pre-Sterilized / Ready-to-Use Primary Packaging Market in Europe, 2021-2030 (USD Billion)
Figure 12.23 Pre-Sterilized / Ready-to-Use Vials Market in Europe, 2021-2030 (USD Billion)
Figure 12.24 Pre-Sterilized / Ready-to-Use Syringes Market in Europe, 2021-2030 (USD Billion)
Figure 12.25 Pre-Sterilized / Ready-to-Use Cartridges Market in Europe, 2021-2030 (USD Billion)
Figure 12.26 Pre-Sterilized / Ready-to-Use Closures Market in Europe, 2021-2030 (USD Billion)
Figure 12.27 Pre-Sterilized / Ready-to-Use Primary Packaging Market in Asia-Pacific, 2021-2030 (USD Billion)
Figure 12.28 Pre-Sterilized / Ready-to-Use Vials Market in Asia-Pacific, 2021-2030 (USD Billion)
Figure 12.29 Pre-Sterilized / Ready-to-Use Syringes Market in Asia-Pacific, 2021-2030 (USD Billion)
Figure 12.30 Pre-Sterilized / Ready-to-Use Cartridges Market in Asia-Pacific, 2021-2030 (USD Billion)
Figure 12.31 Pre-Sterilized / Ready-to-Use Closures Market in Asia-Pacific, 2021-2030 (USD Billion)
Figure 12.32 Pre-Sterilized / Ready-to-Use Primary Packaging Market in Middle East and North Africa, 2021-2030 (USD Billion)
Figure 12.33 Pre-Sterilized / Ready-to-Use Vials Market in Middle East and North Africa, 2021-2030 (USD Billion)
Figure 12.34 Pre-Sterilized / Ready-to-Use Syringes Market in Middle East and North Africa, 2021-2030 (USD Billion)
Figure 12.35 Pre-Sterilized / Ready-to-Use Cartridges Market in Middle East and North Africa, 2021-2030 (USD Billion)
Figure 12.36 Pre-Sterilized / Ready-to-Use Closures Market in Middle East and North Africa, 2021-2030 (USD Billion)
Figure 12.37 Pre-Sterilized / Ready-to-Use Primary Packaging Market in Latin America, 2021-2030 (USD Billion)
Figure 12.38 Pre-Sterilized / Ready-to-Use Vials Market in Latin America, 2021-2030 (USD Billion)
Figure 12.39 Pre-Sterilized / Ready-to-Use Syringes Market in Latin America, 2021-2030 (USD Billion)
Figure 12.40 Pre-Sterilized / Ready-to-Use Cartridges Market in Latin America, 2021-2030 (USD Billion)
Figure 12.41 Pre-Sterilized / Ready-to-Use Closures Market in Latin America, 2021-2030 (USD Billion)
Figure 12.42 Pre-Sterilized / Ready-to-Use Primary Packaging Market in Rest of the World, 2021-2030 (USD Billion)
Figure 12.43 Pre-Sterilized / Ready-to-Use Vials Market in Rest of the World, 2021-2030 (USD Billion)
Figure 12.44 Pre-Sterilized / Ready-to-Use Syringes Market in Rest of the World, 2021-2030 (USD Billion)
Figure 12.45 Pre-Sterilized / Ready-to-Use Cartridges Market in Rest of the World, 2021-2030 (USD Billion)
Figure 12.46 Pre-Sterilized / Ready-to-Use Closures Market in Rest of the World, 2021-2030 (USD Billion)

List Of Tables

Table 3.1 Compatibility of Polymers with Ethylene Oxide Sterilization
Table 3.2 Advantages and Disadvantages Associated with Different Sterilization Techniques
Table 4.1 Pre-Sterilized / Ready-to-Use Primary Packaging: List of Products
Table 4.2 Pre-Sterilized / Ready-to-Use Primary Packaging: List of Manufacturers
Table 6.1 AptarGroup: Company Snapshot
Table 6.2 AptarGroup: Ready-to-Use Closures
Table 6.3 AptarGroup: Recent Developments and Future Outlook
Table 6.4 Datwyler Group: Company Snapshot
Table 6.5 Datwyler Group: Ready-to-Use Closures
Table 6.6 Datwyler Group: Recent Developments and Future Outlook
Table 6.7 DWK Life Sciences: Company Snapshot
Table 6.8 DWK Life Sciences: Ready-to-Use Container-Closure Systems
Table 6.9 DWK Life Sciences: Recent Developments and Future Outlook
Table 6.10 Gerresheimer: Company Snapshot
Table 6.11 Gerresheimer: Ready-to-Use Containers
Table 6.12 Gerresheimer: Recent Developments and Future Outlook
Table 6.13 Ningbo Zhengli Pharmaceutical Packaging: Company Snapshot
Table 6.14 Ningbo Zhengli Pharmaceutical Packaging: Ready-to-Use Containers
Table 6.15 Ningbo Zhengli Pharmaceutical Packaging: Recent Developments and Future Outlook
Table 6.16 Nipro: Company Snapshot
Table 6.17 Nipro: Ready-to-Use Containers
Table 6.18 Nipro: Ready-to-Use Closures
Table 6.19 Nipro: Recent Developments and Future Outlook
Table 6.20 SCHOTT: Company Snapshot
Table 6.21 SCHOTT: Ready-to-Use Containers
Table 6.22 SCHOTT: Ready-to-Use Closures
Table 6.23 SCHOTT: Recent Developments and Future Outlook
Table 6.24 SGD Pharma: Company Snapshot
Table 6.25 SGD Pharma: Ready-to-Use Containers
Table 6.26 SGD Pharma: Recent Developments and Future Outlook
Table 6.27 Stevanato Group: Company Snapshot
Table 6.28 Stevanato Group: Ready-to-Use Containers
Table 6.29 Stevanato Group: Ready-to-Use Closures
Table 6.30 Stevanato Group: Ready-to-Use Container-Closure Systems
Table 6.31 Stevanato Group: Recent Developments and Future Outlook
Table 6.32 Terumo Medical: Company Snapshot
Table 6.33 Terumo Medical: Ready-to-Use Container-Closure Systems
Table 6.34 Terumo Medical: Recent Developments and Future Outlook
Table 6.35 Transcoject: Company Snapshot
Table 6.36 Transcoject: Ready-to-Use Containers
Table 6.37 West Pharmaceutical Services: Company Snapshot
Table 6.38 West Pharmaceutical Services: Ready-to-Use Containers
Table 6.39 West Pharmaceutical Services: Ready-to-Use Closures
Table 6.40 West Pharmaceutical Services: Ready-to-Use Container-Closure Systems
Table 6.41 West Pharmaceutical Services: Recent Developments and Future Outlook
Table 7.1 Pre-Sterilized / Ready-to-Use Primary Packaging: Partnerships and Collaborations, 2015-2020
Table 11.1 List of Pharmaceutical Robotics Manufacturers
Table 11.2. Aseptic Technologies: Company Overview
Table 11.3. Aseptic Technologies: Key Specifications of Crystal L1 Robot Line
Table 11.4. Aseptic Technologies: Key Specifications of Crystal SL1 Robot Line
Table 11.5. AST: Company Overview
Table 11.6. AST: Key Specifications of ASEPTiCell
Table 11.7. AST: Key Specifications of ASEPTiCell VSM-25
Table 11.8. AST: Key Specifications of GENiSYS R
Table 11.9. AST: Key Specifications of GENiSYS C
Table 11.10. AST: Key Specifications of GENiSYS Lab
Table 11.11. Bosch Packaging Technology: Company Overview
Table 11.12. Bosch Packaging Technology: Key Specifications of ATO
Table 11.13. Dara Pharmaceutical Packaging: Company Overview
Table 11.14. Dara Pharmaceutical Packaging: Key Specifications of SYX-E CARTRIDGE + RABS
Table 11.15. Fedegari Group: Company Overview
Table 11.16. Fedegari Group: Key Specifications of Fedegari Isolator
Table 11.17. IMA: Company Overview
Table 11.18. IMA: Key Specifications of INJECTA
Table 11.19. IMA: Key Specifications of STERI LIF3
Table 11.20. Steriline: Company Overview
Table 11.21. Steriline: Key Specifications of Robotic Nest Filling Machine
Table 11.22. Steriline: Key Specifications of Robotic Vial Filling Machine
Table 11.23. Steriline: Key Specifications of Robotic Vial Capping Machine
Table 11.24. Vanrx Pharmasystems: Company Overview
Table 11.25. Vanrx Pharmasystems: Key Specifications of Microcell Vial Filler
Table 11.26. Vanrx Pharmasystems: Key Specifications of SA25 Aseptic Filling Workcell
Table 14.1. Aseptic Technologies: Company Snapshot
Table 14.2. BioPhorum Operations Group: Company Snapshot
Table 14.3. PYRAMID Laboratories: Company Snapshot
Table 14.4. Sagar Rubber: Company Snapshot
Table 15.1 Pre-Sterilized / Ready-to-Use Primary Packaging: Distribution by Type of Primary Packaging System
Table 15.2 Pre-Sterilized / Ready-to-Use Containers: Distribution by Type of Container
Table 15.3 Pre-Sterilized / Ready-to-Use Containers: Distribution by Type of Fabrication Material Used
Table 15.4 Pre-Sterilized / Ready-to-Use Containers: Distribution by Type of Container and Type of Fabrication Material Used
Table 15.5 Pre-Sterilized / Ready-to-Use Containers: Distribution by Sterilization Technique Used
Table 15.6 Pre-Sterilized / Ready-to-Use Containers: Distribution by Type of Container and Sterilization Technique Used
Table 15.7 Pre-Sterilized / Ready-to-Use Containers: Distribution by Volume of Container
Table 15.8 Pre-Sterilized / Ready-to-Use Containers: Distribution by Type of Container and Volume of Container
Table 15.9 Pre-Sterilized / Ready-to-Use Containers: Distribution by Compatible Drug Class
Table 15.10 Pre-Sterilized / Ready-to-Use Containers: Distribution by Type of Container and Compatible Drug Class
Table 15.11 Pre-Sterilized / Ready-to-Use Closures: Distribution by Type of Closure
Table 15.12 Pre-Sterilized / Ready-to-Use Closures: Distribution by Type of Fabrication Material Used
Table 15.13 Pre-Sterilized / Ready-to-Use Closures: Distribution by Type of Closure and Type of Fabrication Material Used
Table 15.14 Pre-Sterilized / Ready-to-Use Closures: Distribution by Type of Compatible Container
Table 15.15 Pre-Sterilized / Ready-to-Use Closures: Distribution by Type of Closure and Type of Compatible Container
Table 15.16 Pre-Sterilized / Ready-to-Use Closures: Distribution by Sterilization Technique Used
Table 15.17 Pre-Sterilized / Ready-to-Use Closures: Distribution by Type of Closure and Sterilization Technique Used
Table 15.18 Pre-Sterilized / Ready-to-Use Closures: Distribution by Compatible Drug Class
Table 15.19 Pre-Sterilized / Ready-to-Use Closures: Distribution by Type of Closure and Compatible Drug Class
Table 15.20 Pre-Sterilized / Ready-to-Use Container-Closure Systems: Distribution by Type of Container
Table 15.21 Pre-Sterilized / Ready-to-Use Container-Closure Systems: Distribution by Type of Fabrication Material Used for Container
Table 15.22 Pre-Sterilized / Ready-to-Use Container-Closure Systems: Distribution by Type of Container and Type of Fabrication Material Used for Container
Table 15.23 Pre-Sterilized / Ready-to-Use Container-Closure Systems: Distribution by Type of Closure
Table 15.24 Pre-Sterilized / Ready-to-Use Container-Closure Systems: Distribution by Type of Fabrication Material Used for Closure
Table 15.25 Pre-Sterilized / Ready-to-Use Container-Closure Systems: Distribution by Type of Closure and Type of Fabrication Material Used for Closure
Table 15.26 Pre-Sterilized / Ready-to-Use Container-Closure Systems: Distribution by Sterilization Technique Used
Table 15.27 Pre-Sterilized / Ready-to-Use Container-Closure Systems: Distribution by Volume of Container
Table 15.28 Pre-Sterilized / Ready-to-Use Container-Closure Systems: Distribution by Compatible Drug Class
Table 15.29 AptarGroup: Annual Revenues, 2016-2020 (USD Billion)
Table 15.30 Datwyler Group: Annual Revenues, 2016-2020 (CHF Billion)
Table 15.31 Gerresheimer Group: Annual Revenues, 2016 – 9M 2020 (EUR Billion)
Table 15.32 Nipro: Annual Revenues, 2016-2020 (JPY Billion)
Table 15.33 SCHOTT: Annual Revenues, 2016-2020 (EUR Billion)
Table 15.34 West Pharmaceutical Services: Annual Revenues, 2016-2020 (USD Billion)
Table 15.35 Partnerships and Collaborations: Cumulative Year-wise Trend, 2015-2020
Table 15.36 Partnerships and Collaborations: Distribution by Type of Partnership
Table 15.37 Partnerships and Collaborations: Year-wise Trend by Type of Partnership
Table 15.38 Partnerships and Collaborations: Distribution by Type of Primary Packaging System
Table 15.39 Partnerships and Collaborations: Year-wise Trend by Type of Primary Packaging System
Table 15.40 Partnerships and Collaborations: Distribution by Type of Fabrication Material Used
Table 15.41 Partnerships and Collaborations: Year-wise Trend by Type of Fabrication Material Used
Table 15.42 Partnerships and Collaborations: Distribution by Analysis by Type of Partner
Table 15.43 Partnerships and Collaborations: Year-wise Trend by Analysis by Type of Partner
Table 15.44 Most Active Players: Distribution by Number of Partnerships
Table 15.45 Partnerships and Collaborations: Distribution by Region (Continent-wise)
Table 15.46 Partnerships and Collaborations: Distribution by Region (Country-wise)
Table 15.47 Pre-Sterilized / Ready to Use Primary Packaging Market, 2021-2030: COVID-19 Impact Scenario (USD Billion)
Table 15.48 Global Demand for Pre-Sterilized / Ready-to-Use Primary Packaging Systems, 2021-2030 (Billion Units)
Table 15.49. Global Demand for Pre-Sterilized / Ready-to-Use Vials, 2021-2030 (Billion Units)
Table 15.50 Global Demand for Pre-Sterilized / Ready-to-Use Syringes, 2021-2030 (Billion Units)
Table 15.51 Global Demand for Pre-Sterilized / Ready-to-Use Cartridges, 2021-2030 (Billion Units)
Table 15.52 Global Demand for Pre-Sterilized / Ready-to-Use Closures, 2021-2030 (Billion Units)
Table 15.53 Global Demand for Pre-Sterilized / Ready-to-Use Primary Packaging System: Distribution by Type of Fabrication Material Used, 2021 and 2030
Table 15.54 Global Demand for Pre-Sterilized / Ready-to-Use Glass Containers, 2021-2030 (Billion Units)
Table 15.55 Global Demand for Pre-Sterilized / Ready-to-Use Glass Vials, 2021-2030 (Billion Units)
Table 15.56 Global Demand for Pre-Sterilized / Ready-to-Use Glass Syringes, 2021-2030 (Billion Units)
Table 15.57 Global Demand for Pre-Sterilized / Ready-to-Use Glass Cartridges, 2021-2030 (Billion Units)
Table 15.58 Global Demand for Pre-Sterilized / Ready-to-Use Plastic Containers, 2021-2030 (Billion Units)
Table 15.59 Global Demand for Pre-Sterilized / Ready-to-Use Plastic Vials, 2021-2030 (Billion Units)
Table 15.60 Global Demand for Pre-Sterilized / Ready-to-Use Plastic Syringes, 2021-2030 (Billion Units)
Table 15.61 Global Demand for Pre-Sterilized / Ready-to-Use Plastic Cartridges, 2021-2030 (Billion Units)
Table 15.62 Global Demand for Pre-Sterilized / Ready-to-Use Primary Packaging System: Distribution by Geography, 2021 and 2030
Table 15.63 Demand for Pre-Sterilized / Ready-to-Use Vials in North America, 2021-2030 (Billion Units)
Table 15.64 Demand for Pre-Sterilized / Ready-to-Use Syringes in North America, 2021-2030 (Billion Units)
Table 15.65 Demand for Pre-Sterilized / Ready-to-Use Cartridges in North America, 2021-2030 (Billion Units)
Table 15.66 Demand for Pre-Sterilized / Ready-to-Use Closures in North America, 2021-2030 (Billion Units)
Table 15.67 Demand for Pre-Sterilized / Ready-to-Use Vials in Europe, 2021-2030 (Billion Units)
Table 15.68 Demand for Pre-Sterilized / Ready-to-Use Syringes in Europe, 2021-2030 (Billion Units)
Table 15.69 Demand for Pre-Sterilized / Ready-to-Use Cartridges in Europe, 2021-2030 (Billion Units)
Table 15.70 Demand for Pre-Sterilized / Ready-to-Use Closures in Europe, 2021-2030 (Billion Units)
Table 15.71 Demand for Pre-Sterilized / Ready-to-Use Vials in Asia Pacific, 2021-2030 (Billion Units)
Table 15.72 Demand for Pre-Sterilized / Ready-to-Use Syringes in Asia Pacific, 2021-2030 (Billion Units)
Table 15.73 Demand for Pre-Sterilized / Ready-to-Use Cartridges in Asia Pacific, 2021-2030 (Billion Units)
Table 15.74 Demand for Pre-Sterilized / Ready-to-Use Closures in Asia Pacific, 2021-2030 (Billion Units)
Table 15.75 Demand for Pre-Sterilized / Ready-to-Use Vials in Middle East and North Africa, 2021-2030 (Billion Units)
Table 15.76 Demand for Pre-Sterilized / Ready-to-Use Syringes in Middle East and North Africa, 2021-2030 (Billion Units)
Table 15.77 Demand for Pre-Sterilized / Ready-to-Use Cartridges in Middle East and North Africa, 2021-2030 (Billion Units)
Table 15.78 Demand for Pre-Sterilized / Ready-to-Use Closures in Middle East and North Africa, 2021-2030 (Billion Units)
Table 15.79 Demand for Pre-Sterilized / Ready-to-Use Vials in Latin America, 2021-2030 (Billion Units)
Table 15.80 Demand for Pre-Sterilized / Ready-to-Use Syringes in Latin America, 2021-2030 (Billion Units)
Table 15.81 Demand for Pre-Sterilized / Ready-to-Use Cartridges in Latin America, 2021-2030 (Billion Units)
Table 15.82 Demand for Pre-Sterilized / Ready-to-Use Closures in Latin America, 2021-2030 (Billion Units)
Table 15.83 Demand for Pre-Sterilized / Ready-to-Use Vials in Rest of the World, 2021-2030 (Billion Units)
Table 15.84 Demand for Pre-Sterilized / Ready-to-Use Syringes in Rest of the World, 2021-2030 (Billion Units)
Table 15.85 Demand for Pre-Sterilized / Ready-to-Use Cartridges in Rest of the World, 2021-2030 (Billion Units)
Table 15.86 Demand for Pre-Sterilized / Ready-to-Use Closures in Rest of the World, 2021-2030 (Billion Units)
Table 15.87 Processing Costs: Distribution by Type of Packaging Component
Table 15.88 Global Pre-Sterilized / Ready-to-Use Primary Packaging Market, 2021-2030: Conservative, Base and Optimistic Scenarios (USD Billion)
Table 15.89 Pre-Sterilized / Ready-to-Use Vials Market, 2021-2030: Conservative, Base and Optimistic Scenarios (USD Billion)
Table 15.90 Pre-Sterilized / Ready-to-Use Syringes Market, 2021-2030: Conservative, Base and Optimistic Scenarios (USD Billion)
Table 15.91 Pre-Sterilized / Ready-to-Use Cartridges Market, 2021-2030: Conservative, Base and Optimistic Scenarios (USD Billion)
Table 15.92 Pre-Sterilized / Ready-to-Use Closures Market, 2021-2030: Conservative, Base and Optimistic Scenarios (USD Billion)
Table 15.93 Pre-Sterilized / Ready-to-Use Primary Packaging Market, 2021-2030: Distribution by Type of Fabrication Material Used (USD Billion)
Table 15.94 Pre-Sterilized / Ready-to-Use Glass Containers Market, 2021-2030: Conservative, Base and Optimistic Scenarios (USD Billion)
Table 15.95 Pre-Sterilized / Ready-to-Use Glass Vials Market, 2021-2030: Conservative, Base and Optimistic Scenarios (USD Billion)
Table 15.96 Pre-Sterilized / Ready-to-Use Glass Syringes Market, 2021-2030: Conservative, Base and Optimistic Scenarios (USD Billion)
Table 15.97 Pre-Sterilized / Ready-to-Use Glass Cartridges Market, 2021-2030: Conservative, Base and Optimistic Scenarios (USD Billion)
Table 15.98 Pre-Sterilized / Ready-to-Use Plastic Containers Market, 2021-2030: Conservative, Base and Optimistic Scenarios (USD Billion)
Table 15.99 Pre-Sterilized / Ready-to-Use Plastic Vials Market, 2021-2030: Conservative, Base and Optimistic Scenarios (USD Billion)
Table 15.100 Pre-Sterilized / Ready-to-Use Plastic Syringes Market, 2021-2030: Conservative, Base and Optimistic Scenarios (USD Billion)
Table 15.101 Pre-Sterilized / Ready-to-Use Plastic Cartridges Market, 2021-2030: Conservative, Base and Optimistic Scenarios (USD Billion)
Table 15.102 Pre-Sterilized / Ready-to-Use Primary Packaging Market, 2021-2030: Distribution by Geography (USD Billion)
Table 15.103 Pre-Sterilized / Ready-to-Use Primary Packaging Market in North America, 2021-2030: Conservative, Base and Optimistic Scenarios (USD Billion)
Table 15.104 Pre-Sterilized / Ready-to-Use Vials Market in North America, 2021-2030: Conservative, Base and Optimistic Scenarios (USD Billion)
Table 15.105 Pre-Sterilized / Ready-to-Use Syringes Market in North America, 2021-2030: Conservative, Base and Optimistic Scenarios (USD Billion)
Table 15.106 Pre-Sterilized / Ready-to-Use Cartridges Market in North America, 2021-2030: Conservative, Base and Optimistic Scenarios (USD Billion)
Table 15.107 Pre-Sterilized / Ready-to-Use Closures Market in North America, 2021-2030: Conservative, Base and Optimistic Scenarios (USD Billion)
Table 15.108 Pre-Sterilized / Ready-to-Use Primary Packaging Market in Europe, 2021-2030: Conservative, Base and Optimistic Scenarios (USD Billion)
Table 15.109 Pre-Sterilized / Ready-to-Use Vials Market in Europe, 2021-2030: Conservative, Base and Optimistic Scenarios (USD Billion)
Table 15.110 Pre-Sterilized / Ready-to-Use Syringes Market in Europe, 2021-2030: Conservative, Base and Optimistic Scenarios (USD Billion)
Table 15.111 Pre-Sterilized / Ready-to-Use Cartridges Market in Europe, 2021-2030: Conservative, Base and Optimistic Scenarios (USD Billion)
Table 15.112 Pre-Sterilized / Ready-to-Use Closures Market in Europe, 2021-2030: Conservative, Base and Optimistic Scenarios (USD Billion)
Table 15.113 Pre-Sterilized / Ready-to-Use Primary Packaging Market in Asia-Pacific, 2021-2030: Conservative, Base and Optimistic Scenarios (USD Billion)
Table 15.114 Pre-Sterilized / Ready-to-Use Vials Market in Asia-Pacific, 2021-2030: Conservative, Base and Optimistic Scenarios (USD Billion)
Table 15.115 Pre-Sterilized / Ready-to-Use Syringes Market in Asia-Pacific, 2021-2030: Conservative, Base and Optimistic Scenarios (USD Billion)
Table 15.116 Pre-Sterilized / Ready-to-Use Cartridges Market in Asia-Pacific, 2021-2030: Conservative, Base and Optimistic Scenarios (USD Billion)
Table 15.117 Pre-Sterilized / Ready-to-Use Closures Market in Asia-Pacific, 2021-2030: Conservative, Base and Optimistic Scenarios (USD Billion)
Table 15.118 Pre-Sterilized / Ready-to-Use Primary Packaging Market in Middle East and North Africa, 2021-2030: Conservative, Base and Optimistic Scenarios (USD Billion)
Table 15.119 Pre-Sterilized / Ready-to-Use Vials Market in Middle East and North Africa, 2021-2030: Conservative, Base and Optimistic Scenarios (USD Billion)
Table 15.120 Pre-Sterilized / Ready-to-Use Syringes Market in Middle East and North Africa, 2021-2030 (USD Billion)
Table 15.121 Pre-Sterilized / Ready-to-Use Cartridges Market in Middle East and North Africa, 2021-2030: Conservative, Base and Optimistic Scenarios (USD Billion)
Table 15.122 Pre-Sterilized / Ready-to-Use Closures Market in Middle East and North Africa, 2021-2030: Conservative, Base and Optimistic Scenarios (USD Billion)
Table 15.123 Pre-Sterilized / Ready-to-Use Primary Packaging Market in Latin America, 2021-2030: Conservative, Base and Optimistic Scenarios (USD Billion)
Table 15.124 Pre-Sterilized / Ready-to-Use Vials Market in Latin America, 2021-2030: Conservative, Base and Optimistic Scenarios (USD Billion)
Table 15.125 Pre-Sterilized / Ready-to-Use Syringes Market in Latin America, 2021-2030: Conservative, Base and Optimistic Scenarios (USD Billion)
Table 15.126 Pre-Sterilized / Ready-to-Use Cartridges Market in Latin America, 2021-2030: Conservative, Base and Optimistic Scenarios (USD Billion)
Table 15.127 Pre-Sterilized / Ready-to-Use Closures Market in Latin America, 2021-2030: Conservative, Base and Optimistic Scenarios (USD Billion)
Table 15.128 Pre-Sterilized / Ready-to-Use Primary Packaging Market in Rest of the World, 2021-2030: Conservative, Base and Optimistic Scenarios (USD Billion)
Table 15.129 Pre-Sterilized / Ready-to-Use Vials Market in Rest of the World, 2021-2030: Conservative, Base and Optimistic Scenarios (USD Billion)
Table 15.130 Pre-Sterilized / Ready-to-Use Syringes Market in Rest of the World, 2021-2030: Conservative, Base and Optimistic Scenarios (USD Billion)
Table 15.131 Pre-Sterilized / Ready-to-Use Cartridges Market in Rest of the World, 2021-2030: Conservative, Base and Optimistic Scenarios (USD Billion)
Table 15.132 Pre-Sterilized / Ready-to-Use Closures Market in Rest of the World, 2021-2030: Conservative, Base and Optimistic Scenarios (USD Billion)

List Of Companies

The following companies and organizations have been mentioned in the report.

  1. ABB
  2. Afton Scientific
  3. ALK Life Science Solutions
  4. Allergy Laboratories
  5. American Nurses Foundation
  6. American Red Cross
  7. AptarGroup
  8. ARaymondlife
  9. Aseptic Technologies
  10. AST
  11. Becton Dickinson
  12. Berkshire Sterile Manufacturing
  13. Bharat Rubber Works
  14. Biomedical Advanced Research and Development Authority 
  15. BioPharma Solutions
  16. Bormioli Pharma
  17. Catalent
  18. Centor
  19. China Lemon Trading
  20. Coalition for Epidemic Preparedness Innovations
  21. COLANAR
  22. Corning
  23. COVID-19 Solidarity Response Fund
  24. Credence MedSystems
  25. Daikyo Seiko
  26. Dara Pharmaceutical Packaging
  27. Datwyler Group
  28. DENSO
  29. Disposable-Lab (Acquired by Amatsigroup)
  30. DWK Life Sciences
  31. EMA Pharmaceuticals
  32. Amatsigroup (Acquired by Eurofins CDMO)
  33. FANUC America
  34. GCL Pharma (Acquired by Bormioli Pharma)
  35. Gerresheimer
  36. Government of Canada
  37. Helapet
  38. Hindustan Syringes and Medical Devices
  39. Huayi Isotopes Company
  40. IMA
  41. ISOLAB
  42. Jiangsu Hualan New Pharmaceutical Material
  43. Kawasaki Heavy Industries
  44. Klenzaids Contamination Controls
  45. KUKA
  46. Marchesini Group
  47. MedCision
  48. MedicoPack 
  49. Merck
  50. Microsoft
  51. Momentive Technologies
  52. Muller + Muller (Acquired by DWK Life Sciences)
  53. Nelson Labs
  54. Nemera
  55. Ningbo Zhengli Pharmaceutical Packaging 
  56. Nipro
  57. No Kid Hungry 
  58. OMRON Industrial Automation
  59. Origin Pharma Packaging
  60. Ott (Acquired by Datwyler Group)
  61. Pall
  62. Pfeiffer Vacuum
  63. Pfizer
  64. Philabundance
  65. Prince Sterilization Services
  66. Qingdao Huaren Medical Product
  67. Radpharm Scientific
  68. Retractable Technologies
  69. Sagar Rubber
  70. Samsung Medical Rubber
  71. Sartorius
  72. SCHOTT
  73. SCHOTT KAISHA
  74. Seiko Epson
  75. SGD Pharma
  76. Sharp
  77. SiO2 Materials Science
  78. Sonata Rubber
  79. Staubli
  80. Steriline
  81. Sterisets International 
  82. Stevanato Group
  83. SureCare
  84. SVM Automatik
  85. Swissfillon
  86. Syntegon
  87. Tekpak
  88. Terumo
  89. Toxikon Europe (Acquired by Sterigenics International)
  90. Transcoject
  91. Triveni Polymers (Acquired by Gerresheimer)
  92. Tyndall National Institute
  93. Universal Medicap
  94. Universal Robots
  95. United Pharmacy Partners (UPPI)
  96. US Government 
  97. Vaccines Manufacturing and Innovation Centre
  98. Vanrx Pharmasystems
  99. Vetter Pharma
  100. VIGHNESH Rubbers
  101. Watson-Marlow Fluid Technology Group
  102. West Pharmaceutical Services
  103. YangZhong Wealth Metal
  104. Yaskawa Electric
  105. Ypsomed

PRICING DETAILS

USD 5,499

This license grants the right of use of the purchased report to a single recipient only (normally the person who buys the report). You may access the material on your computer, as and when required, for your own personal use. You may also print read more

This license grants the right of use of the purchased report by the employees of a business unit at a particular site / office location. The report may be accessed on the computer of any employee within the business unit. You may also print multiple read more

This license entitles the buyer of the report to share, distribute the report (either full or in part) with other employees of the same firm / enterprise. The report may be accessed by any employee of the enterprise and there is no limit on the read more

Discounts available for multiple report purchases
sales@rootsanalysis.com